CLINICAL_TRIALS
withdrawal
· 2017-03-06
Clinical Trial Update: Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer [Phase 1, Phase 2]
Summary
A clinical trial evaluating endoscopic pancreatic duct stenting to relieve obstructive pain in pancreatic cancer patients has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Johns Hopkins University | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: WITHDRAWN